New CellCarta Chinese Mobile Website and WeChat Mini-Program

January 30, 2024

CellCarta has launched its Chinese mobile website and WeChat Mini-Program so we can stay in touch with the growing biopharmaceutical community in China.

The website and mini-program offer two easily accessible resources for Chinese customers to explore how CellCarta’s expert services and solutions can help them overcome the toughest analytical challenges in precision medicine development.

An information-packed web resource for our valued China-based partners

CellCarta brought its vast analytical and biomarker expertise to China, with the opening of our now CAP-accredited Jining laboratory in 2019, expanding its ability to offer truly global precision medicine CRO support.

Now, through the new website, customers can discover the full suite of capabilities and customized solutions available to developers in the region. More specifically, customers can find out more about our:

• Expert flow cytometry services for rapid and accurate immune profiling
• High-quality IHC/IF/ISH assays for greater confidence in tissue biomarker studies
• Well-established and emerging genomic platforms, including real-time PCR and NanoString
• Olink® and Meso Scale Discovery® (MSD) platforms for highly sensitive, multiplexed cytokine/chemokine screening
• ELISpot assays for highly sensitive cytokine detection at the single-cell level

Discover our new website and contact our Jining team to get your project started: www.cellcarta.cn.

A new WeChat mini program

In addition to the new website, CellCarta has also launched a new WeChat mini program, where customers can easily explore our solutions and expertise, browse our science hub, and easily contact our local team— all from within the WeChat app.